SavedAdd your journal

Journals / İstanbul Kuzey Klinikleri / 2015 / Cilt: 2 - Sayı: 2

Analysis of surgically treated gastric cancers: a tertiary hospital experience in Turkey

Tunc EREN
Metin LEBLEBİCİ
Orhan ALİMOGLU
Abdullah SİSİK
Suat AKTAS
Gurhan BAS
Fatih BASAK
Pages
101–106
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Stage 3 was the most common stage found during the study period (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Gastric cancer (GC) is the fifth most common cancer worldwide, and in Turkey, GC is placed among the 10 most frequently seen cancers.
📊
Key Findings & Data:METHODS: All surgically treated GC cases in the General Surgery Department, between January 2009 and January 2014 were retrospectively reviewed.
💡
Conclusion & Impact:Stage 3 was the most common stage found during the study period (p
🔬Design:Review & Systematic Survey
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Gastric cancer (GC) is the fifth most common cancer worldwide, and in Turkey, GC is placed among the 10 most frequently seen cancers. However, analyzing the epidemiology of cancers and improving screening programs for cancers are not still the top priorities for healthcare professionals. This study aims to show distribution of GC based on stages in a tertiary hospital of Istanbul, Turkey. METHODS: All surgically treated GC cases in the General Surgery Department, between January 2009 and January 2014 were retrospectively reviewed. Data including the operation year, the demographic, clinical and histopathological parameters were recorded and statistically analyzed. RESULTS: The study group consisted of 111 patients. Seventy-four (66.66%) patients were men, and 37 (33.33%) patients were women with a mean age of 63.49±11.83 years. Stage 3 and 4 were the most frequently observed stages with 62 and 18 cases, respectively. Stage 3 was the most common stage found during the study period (p

🔖

Cite This Article

EREN, T., LEBLEBİCİ, M., ALİMOGLU, O., SİSİK, A., AKTAS, S., BAS, G., BASAK, F. (2022). Analysis of surgically treated gastric cancers: a tertiary hospital experience in Turkey. İstanbul Kuzey Klinikleri, Cilt: 2 - Sayı: 2, 101–106. https://ajindex.com/articles/551662

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013
  2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33–64
  3. Jackson C, Mochlinski K, Cunningham D. Therapeutic options in gastric cancer: neoadjuvant chemotherapy vs postoperative chemoradiotherapy. Oncology (Williston Park) 2007;21:1084– 7; discussion 1090, 1096–8, 1101
  4. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20
  5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49
  6. Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther 2014;40:250–60
  7. Mohandas KM, Jagannath P. Epidemiology of digestive tract cancers in India. VI. Projected burden in the new millennium and the need for primary prevention. Indian J Gastroenterol 2000;19:74–8
  8. Gultekin M, Boztas G ed. Turkish Ministry of Health Public Health Agency Cancer Statistics 2014
  9. Ministry of Health: National Burden of Disease and Cost Effectiveness Study. Turkish Ministry of Health, Ankara 2004. 106 North Clin Istanbul – NCI 10. Tuncer M. The national cancer control program: short, medium and long term action plan from the global perspective. In: Tuncer M. (ed.) Cancer Control in Turkey. Ministry of Health Publication, Ankara 2008:740
  10. Bor S, Vardar R, Ormeci N, Memik F, Suleymanlar I, Oguz D, et al. Prevalence patterns of gastric cancers in Turkey: model of a developing country with high occurrence of Helicobacter pylori. J Gastroenterol Hepatol 2007;22:2242–5
  11. Sisik A, Kaya M, Bas G, Basak F, Alimoglu O. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev 2013;14:4289–94
  12. Sankaranarayanan R. Screening for cancer in low- and middleincome countries. Ann Glob Health 2014;80:412–7
  13. Erturk MS, Ciçek Y, Ersan Y, Saribeyoğlu K, Doğusoy G, Erginoz E. Analysis of clinicopathological prognostic parameters in adenocarcinoma of the gastric cardia. Acta Chir Belg 2003;103:611–5.